A detailed history of Bank Of Montreal transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 70,001 shares of LXRX stock, worth $58,100. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70,001
Previous 70,001 -0.0%
Holding current value
$58,100
Previous $117,000 6.84%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.54 - $2.28 $46,200 - $68,400
30,000 Added 75.0%
70,001 $117,000
Q1 2024

May 13, 2024

BUY
$1.3 - $3.58 $52,001 - $143,203
40,001 New
40,001 $96,000
Q2 2022

Aug 11, 2022

SELL
$1.31 - $2.69 $15,720 - $32,280
-12,000 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$1.95 - $3.89 $23,400 - $46,680
12,000 New
12,000 $26,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $157M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.